For citations:
Andreev D.A., Zavyalov A.A. Results of clinical developments of early triple negative breast cancer drug treatment: ASCO-2022. City Healthcare. 2022;3(4):122-131. (In Russ.) https://doi.org/10.47619/2713-2617.zm.2022.v.3i4;122-131
Andreev D.A., Zavyalov A.A. Results of clinical developments of early triple negative breast cancer drug treatment: ASCO-2022. City Healthcare. 2022;3(4):122-131. (In Russ.) https://doi.org/10.47619/2713-2617.zm.2022.v.3i4;122-131